Rosenberg, Steven
- Division of Basic Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #210
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$10.7M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#210
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Rosenberg, Steven as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC010984-16ZIAContact PIAdoptive Cell Transfer Immunotherapy of Cancer$5.3Maward amount
- $5.3Maward amount
Award organization
Organizations that administered FY2023 awards listing Rosenberg, Steven as a PI.
FY2023 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardDivision of Basic Sciences - Nci
- 2008$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #699
- 2008Entered Top 25% NationallyRanked #699
- 2008Entered Top 10% NationallyRanked #699
- 2008Entered Top 5% NationallyRanked #699
- 2009$5M Cumulative Funding
- 2009$10M Cumulative Funding
- 2010$25M Cumulative Funding
- 2011Entered Top 1% NationallyRanked #162
- 2013$50M Cumulative Funding
- 2022$100M Cumulative Funding